Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model

被引:82
作者
Shin, Yong-Wook [1 ]
Bae, Eun-Ah [1 ]
Kim, Dong-Hyun [1 ]
机构
[1] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea
关键词
ginsenoside Rg5; ginsenoside Rh3; COX-2; IFN-gamma; psoriasis;
D O I
10.1007/BF02968253
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of a main constituent ginsenoside Rg5 isolated from red ginseng and its metabolite ginsenoside Rh3 in a chronic dermatitis model was investigated. Ginsenosides Rg5 and Rh3 suppressed swelling of oxazolone-induced mouse ear contact dermatitis. These ginsenosides also reduced mRNA expressions of cyclooxygenase-2, interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma. The inhibition of ginsenoside Rh3 was more potent than that of ginsenoside Rg5. These findings suggest that ginsenoside Rh3 metabolized from ginsenoside Rg5 may improve chronic dermatitis or psoriasis by the regulation of IL-1 beta and TNF-alpha produced by macrophage cells and of IFN-gamma produced by Th cells.
引用
收藏
页码:685 / 690
页数:6
相关论文
共 22 条
[1]   Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng [J].
Akao, T ;
Kida, H ;
Kanaoka, M ;
Hattori, M ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) :1155-1160
[2]   The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients [J].
Austin, LM ;
Ozawa, M ;
Kikuchi, T ;
Walters, IB ;
Krueger, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :752-759
[3]   Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities [J].
Bae, EA ;
Han, MJ ;
Choo, MK ;
Park, SY ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (01) :58-63
[4]   Complementary and alternative interventions in asthma, allergy, and immunology [J].
Bielory, L .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (02) :S45-S54
[5]  
Choo MK, 2003, PLANTA MED, V69, P518, DOI 10.1055/s-2003-40653
[6]   Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats [J].
Fujii, Y ;
Takeuchi, H ;
Tanaka, K ;
Sakuma, S ;
Ohkubo, Y ;
Mutoh, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 456 (1-3) :115-121
[7]   Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A:: Roles of the nuclear factor of activated T cells and cyclooxygenase 2 [J].
Hernández, GL ;
Volpert, OV ;
Iñiguez, MA ;
Lorenzo, E ;
Martínez-Martínez, S ;
Grau, R ;
Fresno, M ;
Redondo, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (05) :607-620
[8]   Inhibitory effects of the ginsenoside R93 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion [J].
Keum, YS ;
Han, SS ;
Chun, KS ;
Park, KK ;
Park, JH ;
Lee, SK ;
Surh, YJ .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 523 :75-85
[9]   THE ASSESSMENT OF FUNCTIONAL AGE USING ACTIVITIES OF DAILY LIVING PERFORMANCE TESTS - A STUDY OF KOREAN WOMEN [J].
KIM, HS ;
TANAKA, K .
JOURNAL OF AGING AND PHYSICAL ACTIVITY, 1995, 3 (01) :39-53
[10]   CHEMICAL STUDIES ON CRUDE DRUG PRECESSION .1. ON THE CONSTITUENTS OF GINSENG RADIX RUBRA [J].
KITAGAWA, I ;
YOSHIKAWA, M ;
YOSHIHARA, M ;
HAYASHI, T ;
TANIYAMA, T .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1983, 103 (06) :612-622